BeiGene vs Relay Therapeutics
BeiGene vs Relay Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and Relay Therapeutics on 58/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 58/100
- agent readiness: 50/100 against 39/100
- domain rating: 68/100 against 45/100
Relay Therapeutics
- funding raised: $825M against $358M
At a glance
| Measure | BeiGene | Relay Therapeutics |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | Clinical-stage precision medicine company using protein motion insights for drug discovery. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Precision Medicine, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2010 | 2015 |
| Headquarters | Cambridge, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | Relay Therapeutics |
|---|---|---|
| Open roles | 100 | Not published |
| Total funding | $358M | $825M |
| Latest round | Secondary Offering | Public Offering |
| Valuation | $15B | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | Relay Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 58/100 |
| Traction | 40/100 | 40/100 |
| Team | 30/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 17/100 | 14/100 |
| Quality | 88/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 45/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | Relay Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Jquery |
| Analytics | Not detected | Linkedin Insight |
BeiGene vs Relay Therapeutics: common questions
Which is better, BeiGene or Relay Therapeutics?
On our 0-100 score BeiGene rates higher (64/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do BeiGene and Relay Therapeutics compare on the numbers?
BeiGene leads on our overall score (64/100 against 58/100), agent readiness (50/100 against 39/100), domain rating (68/100 against 45/100). Relay Therapeutics leads on funding raised ($825M against $358M).
Read the full BeiGene review and pricing or the Relay Therapeutics review and pricing. You can also browse other BeiGene alternatives we track.